Harvard Apparatus Regenerative Technology, Inc. (HRGN): R&D Expense
$2.65M
Year ended 2025-12-31
$2.87M
Trailing 12 months to 2026-06-30
+15.1%
3-year compound annual growth
+5.1%
5-year compound annual growth
-5.7%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.65M | +14.8% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $2.31M | -24.6% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $3.06M | +75.8% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $1.74M | +9.4% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $1.59M | -23.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $2.07M | -57.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $4.85M | +23.9% | 2021-04-13, From 2019-01-01 |
| 2018-12-31 | $3.92M | -48.4% | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | $7.59M | -0.2% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $7.60M | +58.9% | 2018-04-03, From 2016-01-01 |
| 2015-12-31 | $4.79M | -6.5% | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | $5.12M | +12.2% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $4.56M | +13.3% | 2015-03-27, From 2013-01-01 |
| 2012-12-31 | $4.03M | n/a | 2014-03-31, From 2012-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $44.72M | +38.3% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
Compare HRGN, CODX, VTAK, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗